# Wave Life Sciences (WVE) — Analyst Forecast

WVE · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/wve/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 18 | 0 | 0 | 18 |

## Price target

| Low | Average | High | Analysts |
| --- | --- | --- | --- |
| $10.00 | $16.17 | $23.00 | 6 |

Last price $3.19 (as of Oct 16, 2026).

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Oct 15, 2026 | UBS | Initiated Coverage | Buy | $11.00 |
| Oct 1, 2026 | Ladenburg Thalmann | Initiated Coverage | Buy | $10.00 |
| Sep 23, 2026 | JP Morgan | Downgraded | Overweight → Neutral | — |
| Aug 4, 2026 | Mizuho | Maintained | Outperform | $23.00 |
| Jul 31, 2026 | Wedbush | Maintained | Outperform | $12.00 |
| Jul 31, 2026 | B. Riley Securities | Maintained | Buy | $22.00 |
| Jul 31, 2026 | Citigroup | Maintained | Buy | $19.00 |
| May 20, 2026 | Wells Fargo | Maintained | Overweight | $14.00 |
| May 19, 2026 | HC Wainwright & Co. | Maintained | Buy | $13.00 |
| May 4, 2026 | Citigroup | Maintained | Buy | $24.00 |
| Apr 30, 2026 | Canaccord Genuity | Maintained | Buy | $43.00 |
| Apr 29, 2026 | Truist Securities | Maintained | Buy | $15.00 |
| Apr 14, 2026 | HC Wainwright & Co. | Maintained | Buy | $18.00 |
| Mar 27, 2026 | Wells Fargo | Maintained | Overweight | $13.00 |
| Mar 27, 2026 | B of A Securities | Maintained | Buy | $21.00 |
| Mar 25, 2026 | Mizuho | Maintained | Outperform | $27.00 |
| Mar 10, 2026 | Canaccord Genuity | Maintained | Buy | $52.00 |
| Mar 6, 2026 | Wedbush | Maintained | Outperform | $35.00 |
| Mar 2, 2026 | HC Wainwright & Co. | Maintained | Buy | $30.00 |
| Feb 12, 2026 | Wells Fargo | Maintained | Overweight | $27.00 |

## Frequently Asked Questions

### What is the price target for WVE stock?

The average 12-month analyst price target for Wave Life Sciences (WVE) is $16.17, with a high estimate of $23.00 and a low of $10.00, across 6 analysts.

### Is WVE a buy, sell, or hold?

Analysts covering Wave Life Sciences currently average a Buy rating: 18 buy, 0 hold and 0 sell, from 18 analysts. Ratings reflect analyst opinion, not investment advice.

### What upside do analysts see for WVE?

The average price target of $16.17 implies 406.79% upside from the last price of $3.19.

### What is the latest analyst rating on WVE?

On Oct 15, 2026, UBS initiated coverage of Wave Life Sciences at Buy with a price target of $11.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).